Opportunistic Oral HSV-- Mechanisms of Reactivation

机会性口腔 HSV——再激活机制

基本信息

  • 批准号:
    6765093
  • 负责人:
  • 金额:
    $ 26.53万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2001
  • 资助国家:
    美国
  • 起止时间:
    2001-08-01 至 2006-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION: (Provided by Applicant) Human Immunodeficiency Virus (HIV) infection is characterized by recurrent oral disease caused by HSV-1. The defining hallmark of HSV-1 is reactivation from latency. Following stress (heat, trauma, ultra violet light, etc.) viral transcription is induced resulting in HSV-1 reactivation. The mechanism regulating the switch between latency and reactivation is poorly understood. The broad objectives of this proposal are to determine the viral gene sequences required for HSV-1 reactivation in vitro and in vivo during normal and compromised immune function. The central hypothesis to be tested is that stress induced HSV-1 genes are critical for reactivation from latency. Aim one will test the hypothesis that specific HSV-1 genes are induced by stress. Transient transfection of neurally differentiated (ND)-PC12 cells and the firefly lucifease (LUC) assay will be used to determine whether HSV-1 (i.e., alpha genes: alpha 0, alpha 4, alpha 22, alpha 27, and alpha 47, beta genes: ul9 ul23, ul39 and the gamma gene ul48 and LAT) are transcriptionally induced by heat stress and forskolin treatment in the absence of other viral gene products. Aim 2 will identify cis elements that mediate stress responsiveness of HSV-1 promoters using the LUC assay, electrophoretic mobility shift assay (EMSA) and DNA footprinting. Sequentially deleted constructs of HSV-1 promoters will be analyzed for loss of stress responsiveness in the (ND)-PCI2 cells using the LUC assay. Regions identified by standard, competition and super shift EMSA and foot printing will be assessed for stress responsiveness by mutational analysis in the LUC assay. Aim 3 will test the hypothesis that stress response elements in HSV-1 genes are required for reactivation in vitro and in vivo. The cis regulatory elements of HSV-1 genes governing the stress response will be mutated and introduced into the viral genome using recombination techniques. Mutant viruses will be tested in parallel with the rescued virus and parental virus in the PC12 cell culture model for quiescent HSV infection that was developed during their previous NIH funding. Mutant viruses that maintain wild type lytic growth properties and display at least 50 percent reduction in reactivation phenotype will be tested in the immunocompetent and immunosuppressed mouse and rabbit eye models of reactivation to determine whether altered reactivation in vitro correlates with that seen in vivo. The coordinate sequential pattern of gene expression (immediate early, early, late) of the parental, mutant and rescued viruses during the establishment and reactivation phases of quiescence will be analyzed by RT-PCR. These studies will advance the understanding of the molecular biological principals that govern the process of HSV-1 reactivation in immunocompetent and immunosuppressed individuals and could lead to the development of novel antiviral agents that block reactivation in patients with Acquired Immunodeficiency Syndrome (AIDS).
描述:(申请人提供)人类免疫缺陷病毒(HIV) 感染的特征是由HSV-1引起的复发性口腔疾病。的 定义HSV-1的标志是从潜伏期再激活。以下强制降解 (heat创伤、紫外线等)病毒转录被诱导 导致HSV-1再活化。调节两种模式之间的转换的机制 对潜伏期和再激活了解甚少。这一广泛目标 这项研究的目的是确定HSV-1所需的病毒基因序列, 在正常和受损免疫过程中的体外和体内再活化 功能待检验的中心假设是应激诱导HSV-1 基因对于从潜伏期重新激活至关重要。目标一将测试 假设特定HSV-1基因由应激诱导。瞬态 神经分化(ND)-PC 12细胞和萤火虫的转染 荧光素酶(LUC)测定将用于确定HSV-1(即,阿尔法 基因:α 0、α 4、α 22、α 27和α 47,β基因:ul 9 ul 23、ul 39和γ基因ul 48和LAT)是由 热应激和毛喉素治疗在其他病毒基因的情况下 产品.目标2将确定介导应激反应的顺式元件 使用LUC试验、电泳迁移率变动试验 (EMSA)和DNA足迹。HSV-1启动子的序列缺失构建体 将分析(ND)-PCI 2细胞中应激反应性的丧失, LUC测定。通过标准、竞争和超级转移EMSA确定的区域 和足迹将通过突变评估应激反应。 在LUC测定中进行分析。目标3将检验压力反应 HSV-1基因中的元件是体外和体内再活化所必需的。的 控制应激反应的HSV-1基因的顺式调节元件将被 突变并使用重组技术引入病毒基因组。 突变病毒将与拯救病毒和亲本病毒平行检测 在静止期HSV感染的PC 12细胞培养模型中, 在他们之前的NIH资助期间开发的。保持野生状态的变异病毒 类型裂解生长特性,并显示至少50%的减少, 再活化表型将在免疫活性和 免疫抑制小鼠和兔眼模型的再激活,以确定 体外改变的再活化是否与体内观察到的相关。的 基因表达的协调顺序模式(立即早期,早期,晚期) 在建立过程中的亲本、突变体和拯救病毒, 通过RT-PCR分析静止的再活化阶段。这些研究 将促进对分子生物学原理的理解, 控制免疫活性细胞中HSV-1再活化的过程, 免疫抑制的个体,并可能导致新的发展 抗病毒药物阻断获得性白细胞增多症患者的再激活 免疫缺陷综合症(艾滋病)。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CRAIG S MILLER其他文献

CRAIG S MILLER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CRAIG S MILLER', 18)}}的其他基金

Delivery of Polyphenols in Gum for Treatment of Gingivitis
在牙龈中输送多酚以治疗牙龈炎
  • 批准号:
    7664694
  • 财政年份:
    2009
  • 资助金额:
    $ 26.53万
  • 项目类别:
Delivery of Polyphenols in Gum for Treatment of Gingivitis
在牙龈中输送多酚以治疗牙龈炎
  • 批准号:
    8312757
  • 财政年份:
    2009
  • 资助金额:
    $ 26.53万
  • 项目类别:
Delivery of Polyphenols in Gum for Treatment of Gingivitis
在牙龈中输送多酚以治疗牙龈炎
  • 批准号:
    8538937
  • 财政年份:
    2009
  • 资助金额:
    $ 26.53万
  • 项目类别:
Effects of ART on Oral Epithelial Cell Biology
ART 对口腔上皮细胞生物学的影响
  • 批准号:
    7478816
  • 财政年份:
    2007
  • 资助金额:
    $ 26.53万
  • 项目类别:
Effects of ART on Oral Epithelial Cell Biology
ART 对口腔上皮细胞生物学的影响
  • 批准号:
    7276493
  • 财政年份:
    2007
  • 资助金额:
    $ 26.53万
  • 项目类别:
Opportunistic Oral HSV-- Mechanisms of Reactivation
机会性口腔 HSV——再激活机制
  • 批准号:
    6516664
  • 财政年份:
    2001
  • 资助金额:
    $ 26.53万
  • 项目类别:
Opportunistic Oral HSV-- Mechanisms of Reactivation
机会性口腔 HSV——再激活机制
  • 批准号:
    6634708
  • 财政年份:
    2001
  • 资助金额:
    $ 26.53万
  • 项目类别:
Opportunistic Oral HSV-- Mechanisms of Reactivation
机会性口腔 HSV——再激活机制
  • 批准号:
    6887768
  • 财政年份:
    2001
  • 资助金额:
    $ 26.53万
  • 项目类别:
Opportunistic Oral HSV-- Mechanisms of Reactivation
机会性口腔 HSV——再激活机制
  • 批准号:
    7266735
  • 财政年份:
    2001
  • 资助金额:
    $ 26.53万
  • 项目类别:
Opportunistic Oral HSV-- Mechanisms of Reactivation
机会性口腔 HSV——再激活机制
  • 批准号:
    6344412
  • 财政年份:
    2001
  • 资助金额:
    $ 26.53万
  • 项目类别:

相似海外基金

A targeted combination intervention approach for acute HIV infections to curb the explosive epidemic among high-risk populations in Indonesia
针对急性艾滋病毒感染的针对性组合干预方法,遏制印度尼西亚高危人群的爆发性流行
  • 批准号:
    MR/V035304/1
  • 财政年份:
    2022
  • 资助金额:
    $ 26.53万
  • 项目类别:
    Research Grant
IMPAACT RELATED PROTOCOLS FOR THE RESEARCH ON TREATMENT, PREVENTION, DIAGNOSIS AND EPIDEMIOLOGY OF HIV INFECTIONS
HIV 感染的治疗、预防、诊断和流行病学研究的影响相关方案
  • 批准号:
    10369859
  • 财政年份:
    2021
  • 资助金额:
    $ 26.53万
  • 项目类别:
Determining the mechanisms of vascular CD8 T cell activation in CMV and HIV infections
确定 CMV 和 HIV 感染中血管 CD8 T 细胞激活的机制
  • 批准号:
    10461964
  • 财政年份:
    2021
  • 资助金额:
    $ 26.53万
  • 项目类别:
Determining the mechanisms of vascular CD8 T cell activation in CMV and HIV infections
确定 CMV 和 HIV 感染中血管 CD8 T 细胞激活的机制
  • 批准号:
    10326617
  • 财政年份:
    2021
  • 资助金额:
    $ 26.53万
  • 项目类别:
Combination HIV Prevention: Using anti-retroviral and anti-inflammatory medications to prevent new HIV infections
HIV 联合预防:使用抗逆转录病毒和抗炎药物预防新的 HIV 感染
  • 批准号:
    404211
  • 财政年份:
    2018
  • 资助金额:
    $ 26.53万
  • 项目类别:
    Operating Grants
BALTIMORE: PROJECTS TO REDUCE HIV INFECTIONS AND IMPROVE ENGAGEMENT IN HIV MEDICAL CARE AMONG MSM
巴尔的摩:减少艾滋病毒感染和提高男男性行为者参与艾滋病毒医疗护理的项目
  • 批准号:
    9078083
  • 财政年份:
    2015
  • 资助金额:
    $ 26.53万
  • 项目类别:
Health Department Demonstration Projects to Reduce HIV Infections and Improve Engagement in HIV Medical Care among Men Who Have Sex with Men (MSM) and Transgender Persons
卫生部示范项目旨在减少男男性行为者 (MSM) 和跨性别者的艾滋病毒感染并提高他们对艾滋病毒医疗护理的参与度
  • 批准号:
    9079323
  • 财政年份:
    2015
  • 资助金额:
    $ 26.53万
  • 项目类别:
REDUCING HIV INFECTIONS AND IMPROVING ENGAGEMENT IN HIV MEDICAL CARE AMONG MSM IN MEMPHIS TN
减少田纳西州孟菲斯市 MSM 的 HIV 感染并提高其对 HIV 医疗护理的参与度
  • 批准号:
    9079336
  • 财政年份:
    2015
  • 资助金额:
    $ 26.53万
  • 项目类别:
Double-Negative T cells in SIV and HIV Infections
SIV 和 HIV 感染中的双阴性 T 细胞
  • 批准号:
    8472130
  • 财政年份:
    2012
  • 资助金额:
    $ 26.53万
  • 项目类别:
REDUCING HIV INFECTIONS AMONG COMMERCIAL SEX WORKERS IN GERT SIBANDE DISTRICT TAV
减少格特西班德区 TAV 商业性工作者的艾滋病毒感染
  • 批准号:
    8532661
  • 财政年份:
    2011
  • 资助金额:
    $ 26.53万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了